Dolutegravir plus lamivudine maintain HIV-1 suppression...

  • Main
  • 2017 / 12
  • Dolutegravir plus lamivudine maintain HIV-1 suppression...
Clinical Infectious Diseases 2017 / 12

Dolutegravir plus lamivudine maintain HIV-1 suppression through week 48 in a pilot randomized trial

Taiwo, Babafemi O, Marconi, Vincent C, Berzins, Baiba, Moser, Carlee B, Nyaku, Amesika N, Fichtenbaum, Carl J, Benson, Constance A, Wilkin, Timothy, Koletar, Susan L, Colasanti, Jonathan, Acosta, Edwa
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Infectious Diseases
DOI:
10.1093/cid/cix1131
Date:
December, 2017
File:
PDF, 424 KB
english, 2017
Conversion to is in progress
Conversion to is failed